← Back to Search

VIA Disc NP for Discogenic Pain

N/A
Recruiting
Research Sponsored by VIVEX Biologics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6, & 12 months
Awards & highlights
No Placebo-Only Group

Summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Eligible Conditions
  • Discogenic Pain
  • Lower Back Pain
  • Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6, & 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6, & 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Frequency of Pain Medication Use
Numeric Pain Rating Scale (NPRS)
Oswestry Disability Index (ODI)
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: VIA Disc NPExperimental Treatment1 Intervention
Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment

Find a Location

Who is running the clinical trial?

VIVEX Biologics, Inc.Lead Sponsor
8 Previous Clinical Trials
499 Total Patients Enrolled
1 Trials studying Discogenic Pain
83 Patients Enrolled for Discogenic Pain
Moxie ClinicalUNKNOWN
Jasmine WilsonStudy Directorcro
~333 spots leftby Jan 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top